Ralf Müller-Terpitz is Director of the Institute for German, European and International Medical Law, Health Law and Bioethics. His research focusses on the law of reproductive medicine, stem cell research and genetic diagnostics.
Ralf Müller-Terpitz has been working on legal issues in biomedicine for more than 20 years. He habilitated at the University of Bonn in 2005 with a thesis on the protection of prenatal life in the biomedical age. After a six-year professorship at the University of Passau, he accepted an appointment at the University of Mannheim in 2013. There he holds the Chair of Public Law, Law of Economic Regulation and Media. In biomedicine, his research focuses on the law of reproductive medicine, stem cell research and genetic diagnostics. Müller-Terpitz is also a member of the working group "Genetic Engineering Report" at the Berlin Institute of Healh (BIH), Chairman of the Ethics Committee of the University of Mannheim and a member of the Ethics Committee of the Medical Faculty of the University of Heidelberg. In addition to biomedicine, Ralf Müller-Terpitz researches issues of internet and media law. Since 2009, he has been a member of the Commission for Determining Concentration in the Media (KEK), a body of the German state media authorities to ensure diversity of opinion in nationwide television and adjacent media markets.
Further information: Universität Mannheim/Ralf Müller-Terpitz